Genetesis is a privately held medical technology company oriented towards the development of efficient and non-invasive cardiac current density mapping. Our technology utilizes the body’s weak magnetic fields to reconstruct, computationally, areas of high and low electrical conductivity in the heart. Our software, the Genetesis CardioFlux Mapping System, is able to characterize deep sources of current that are consistently missed by the EKG, and does so with the utmost accuracy and predictiveness.
September 5, 2013
CEO: Peeyush Shrivastava
CFO: Chandan Srivastava, M.B.A.
VP R&D: Vineet Erasala
Please click here for Genetesis' job opportunities.
Please click here for Genetesis' technology.